De Remediis is a peer-reviewed english-language open-access journal published by University of Debrecen, Faculty of Pharmacy in Hungary, operating under an open-access model since 2024. The journal covers Therapeutics. Pharmacology.
Authors publish in De Remediis without paying any article processing charge (APC) — making it a fully diamond/platinum open-access venue, supported entirely by its publisher or sponsor. Articles are released under the CC BY license (see other journals using this license).
To date, De Remediis has published 17 articles. Articles are minted with DOIs through the prefix 10.71116.
Keywords
pharmaceutical technology, pharmaceutical chemistry, biopharmaceutics, pharmacology, pharmacognosy, cell biology
At a glance
ISSN
- electronic
- 3058-0358
Frequently asked questions
Is De Remediis peer-reviewed?
Yes — De Remediis operates a Anonymous peer review review process.
Does De Remediis charge an article processing charge (APC)?
No. De Remediis does not charge any APC. Publication is free for accepted authors.
What subjects does De Remediis publish?
De Remediis publishes research in Therapeutics. Pharmacology.
What languages does De Remediis accept?
De Remediis accepts manuscripts in English.
What is the ISSN of De Remediis?
ISSN:
3058-0358 (electronic).How do I submit a manuscript to De Remediis?
Submit through the journal's official portal: visit submission page →